Browsing: Biomarker

This thought-provoking retrospective cohort suggests serum (yes, circulating soluble) PD-L1 is uniquely elevated in patients with aggressive, as opposed to…

A Japanese retrospective look at patients with newly diagnosed non-small cell lung cancer reports median survival times of 11 months…